Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

39.46USD
17 May 2019
Change (% chg)

$0.12 (+0.31%)
Prev Close
$39.34
Open
$39.27
Day's High
$39.68
Day's Low
$39.27
Volume
1,924,392
Avg. Vol
2,761,191
52-wk High
$42.36
52-wk Low
$36.41

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Philip Hampton

64 2015 Non-Executive Chairman of the Board

Emma Walmsley

48 2017 Chief Executive Officer, Executive Director

Iain Mackay

55 2019 Chief Financial Officer, Executive Director

Roger Connor

2018 President - Vaccines

Brian McNamara

50 2016 Chief Executive Officer - GSK Consumer Healthcare